Changeflow GovPing Healthcare Syremis Therapeutics Trademark Publication
Routine Notice Added Final

Syremis Therapeutics Trademark Publication

Favicon for changeflow.com ChangeBridge: Trademarks - Medical Services (Class 044)
Published March 20th, 2026
Detected March 25th, 2026
Email

Summary

The United States Patent and Trademark Office (USPTO) has published the trademark application for SYREMIS THERAPEUTICS for opposition. The application covers a wide range of services including pharmaceutical research, development, retail, and medical services.

What changed

The USPTO has published the trademark application TM79446160 for SYREMIS THERAPEUTICS, initiating a period for opposition. The application seeks to register trademarks for extensive services related to pharmaceuticals and medical products, encompassing research and development, AI/machine learning software design, retail and wholesale distribution, business consulting, advertising, and educational services.

This publication signifies a step in the trademark registration process. While not a regulatory rule, it is a public notice that interested parties have a window to file objections. Companies operating in the pharmaceutical and medical services sectors should be aware of new trademark filings that may overlap with their own branding or services, particularly if they intend to oppose the registration.

Source document (simplified)

← USPTO Trademark Applications

SYREMIS THERAPEUTICS

Published for Opposition TM79446160 Kind: published Mar 20, 2026

Abstract

Research services in the field of pharmaceuticals and medical products; scientific research and technological consulting services in the field of product development in the field of pharmaceuticals; scientific research and technological consulting services in the field of design and product development in the field of pharmaceuticals; industrial analysis, industrial research and industrial design and development services in the field of pharmaceuticals and medical products; design and development of artificial intelligence and machine learning software for use in the field of pharmaceuticals and medical products; design and development of products in the field of pharmaceuticals; development and design services relating to pharmaceutical preparations and medical products; molecule discovery services for use in the development of pharmaceuticals.; Retail and wholesale services, namely, retail and wholesale stores featuring pharmaceutical preparations, medicines, medical, surgical and dental apparatus and instruments, nutritional supplements, vitamins, mineral supplements; business management services; providing office functions; import agencies; sales promotion services; business consulting services; business information services; public relations services; electronic commerce services, namely, providing information about products via telecommunication networks for advertising and sales purposes; purchase and rental of advertising space; direct mail advertising; business networking; arranging of business introductions; advertising, marketing and promotional services relating to pharmaceuticals and medical products; marketing and promotion of pharmaceutical preparations and medical products; market research services relating to pharmaceuticals and medical products; business surveys and the collection of data relating to pharmaceuticals, medical products and medical activities; commercial information and consumer advice relating to pharmaceuticals, medical products and medical information; organization of trade and commercial conferences and conventions relating to pharmaceuticals and medical products; distribution of samples; price comparison services and procurement services for others in the field of pharmaceuticals and medical products.; Organization of business conferences and conventions relating to pharmaceuticals and medical products; educational and training services relating to pharmaceutical preparations and medical products.; Medical services; veterinary services; hygienic and beauty care for human beings or animals.; Pharmaceutical and medical preparations for the treatment of psychiatry, central nervous system, gastrointestinal, hepatic, biliary, immunological, allergic, inflammatory, metabolic, autoimmune and neurological diseases and disorders; pharmaceutical preparations for the relief of pain and anesthesia; pharmaceutical, vegetal, herbal and natural preparations and substances for the treatment of anxiety and depression; vitamins; minerals as food supplements; food supplements; nutritional supplements; chemical preparations for pharmaceutical purposes, namely, for the treatment of central nervous system, gastrointestinal, hepatic, biliary, immunological, allergic, inflammatory, metabolic, autoimmune, neurological, psychiatric and pediatric diseases and disorders; diagnostic preparations for medical use; diagnostic reagents for medicinal use; veterinary preparations; medicated gels, creams and lubricants.

Filing Date

2026-02-05

View original document →

Classification

Agency
USPTO
Published
March 20th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
TM79446160

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies Healthcare providers
Industry sector
3254 Pharmaceutical Manufacturing 6211 Healthcare Providers
Activity scope
Trademark Registration Pharmaceutical Research & Development Medical Services
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Legal
Topics
Trademarks Intellectual Property Medical Services

Get Healthcare alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: Trademarks - Medical Services (Class 044) publishes new changes.

Free. Unsubscribe anytime.